Immunometabolism as predictor of frailty

Johanna M Gostner¹, Blanca Laffon^{2

3}, Thomas K Felder⁴

Affiliations

¹ Institute of Medical Biochemistry, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
² Universidade da Coruña, Grupo DICOMOSA, Centro de Investigaciones Científicas Avanzadas (CICA), Departamento de Psicología, Facultad de Ciencias de la Educación, Campus Elviña s/n, A Coruña 15071, Spain.
³ Instituto de Investigación Biomédica de A Coruña (INIBIC), AE CICA-INIBIC. Oza, A Coruña 15071, Spain.
⁴ Department of Laboratory Medicine, Paracelsus Medical University, Salzburg, Austria.

Editorial

Johanna M Gostner et al. Aging (Albany NY). 2021.

. 2021 Nov 30;13(23):24917-24918.

doi: 10.18632/aging.203737. Epub 2021 Nov 30.

Johanna M Gostner¹, Blanca Laffon^{2

3}, Thomas K Felder⁴

¹ Institute of Medical Biochemistry, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
² Universidade da Coruña, Grupo DICOMOSA, Centro de Investigaciones Científicas Avanzadas (CICA), Departamento de Psicología, Facultad de Ciencias de la Educación, Campus Elviña s/n, A Coruña 15071, Spain.
³ Instituto de Investigación Biomédica de A Coruña (INIBIC), AE CICA-INIBIC. Oza, A Coruña 15071, Spain.
⁴ Department of Laboratory Medicine, Paracelsus Medical University, Salzburg, Austria.

No abstract available

Keywords: frailty; immunometabolism; indoleamine-2,3-dioxygenase; inflammaging; tryptophan.

References

1. Nikolich-Žugich J. Nat Immunol. 2018; 19:10–19. 10.1038/s41590-017-0006-x - DOI - PubMed
1. Marcos-Pérez D, et al. Front Immunol. 2018; 9:1056. 10.3389/fimmu.2018.01056 - DOI - PMC - PubMed
1. Badawy AA. Neuropharmacology. 2017; 112:248–63. 10.1016/j.neuropharm.2015.11.015 - DOI - PubMed
1. Gostner JM, et al. Neuropsychobiology. 2020; 79:89–99. 10.1159/000496293 - DOI - PubMed
1. Jang IY, et al. Aging (Albany NY). 2020; 12:22253–65. 10.18632/aging.104179 - DOI - PMC - PubMed